Elliott also has a stake in German lab-equipment supplier Sartorius, where Bio-Rad is also an investor.

Activist investor Elliott Investment Management has reportedly built a significant stake in Bio-Rad Laboratories Inc. (NYSE: ...

Bio-Rad Laboratories Inc (NYSE:BIO) presented its fourth quarter and full-year 2025 financial results on February 12, 2026, revealing modest overall growth driven primarily by its Clinical Diagnostics ...

RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 8:30 AM EDTCompany ParticipantsRoop Lakkaraju ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming in ...

Bio-Rad Laboratories, Inc. BIO is well-poised to grow in the upcoming quarters, courtesy of its strong traction in the QX600 Droplet Digital PCR (ddPCR) platform. Demand for its quality control and ...

Bio-Rad Laboratories BIO is something of a rarity: a small-cap company with a wide economic moat. The company develops products and solutions for the clinical diagnostics and life sciences industries, ...

May 17 (Reuters) - Activist investor Elliott Investment Management has built a sizeable stake in U.S. diagnostics supplier Bio-Rad Laboratories, and plans to push the company to boost its ...